Authors | Age y/o | Type ofrenal alteration | Serum creatinine | Proteinuria | PSA | Therapy for prostatic cancer | Therapy of nephrotic syndrome | Outcome |
Stuart K, 1986 | n/a | MN | n/a | n/a | n/a | n/a | CS | Remission |
Haskell L.P and al. 1990 | 81 | CGN | n/a | n/a | n/a | Orchiectomy; DES + RT | CS | Died |
Pai P and al. 1996 | n/a | MPGN | 133 (μmol/l) | 7.4 g/day | n/a | DES | CS | Remission |
Matsuura H, 2000 | 74 | MN | n/a | 12.9 g/day | 290 ng/ml | DES | CS | Remission |
Ahmed MS, 2007 | 75 | MPGN | 85 (μmol/l) | 5.5 g/day | n/a | CPA | CS | Remission |
Fradet Y, 2010 (unpublished data, personal communication) | 71 | MN | 72 (μmol/l) | 16.7 g/day | 93 ng/ml | RP + RT | CS + CSF | Remission |